SEC Form 4 · accession 0001209191-18-058302
Outlook Therapeutics, Inc. · OTLK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Randy H Thurman
Director
Period of report
Nov 9, 2018
Accepted (ET)
Nov 13, 2018 · 4:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001649989
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2,F1 | $0.89 | Nov 9, 2018 | A | 567,522 | A | — | Nov 9, 2028 | Common Stock | 567,522 | 567,522 | D |
Explanation of responses
- F1Immediately exercisable.
- F2This option was issued to the Reporting Person pursuant to the Issuer's 2015 Equity Incentive Plan in lieu of two years of cash retainer and meeting fees, including Executive Chairman fee, of $348,000.